Massachusetts Financial Services CO Bio Atla, Inc. Transaction History

Massachusetts Financial Services CO

$320 Billion
Q3 2024

A detailed history of Massachusetts Financial Services CO transactions in Bio Atla, Inc. stock. As of the latest transaction made, Massachusetts Financial Services CO holds 569,332 shares of BCAB stock, worth $916,624. This represents 0.0% of its overall portfolio holdings.

Number of Shares

569,332

Previous 541,199 5.2%

Holding current value

$916,624

Previous $741,000 35.22%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$1.17 - $2.05 $32,915 - $57,672	28,133 Added 5.2%	569,332 $1 Million
Q2 2024 Aug 09, 2024	BUY	$1.37 - $3.92 $20,189 - $57,769	14,737 Added 2.8%	541,199 $741,000
Q1 2024 May 14, 2024	SELL	$1.88 - $3.46 $5,064 - $9,321	-2,694 Reduced 0.51%	526,462 $1.81 Million
Q4 2023 Feb 08, 2024	BUY	$1.27 - $3.18 $621 - $1,555	489 Added 0.09%	529,156 $1.3 Million
Q3 2023 Nov 08, 2023	SELL	$1.7 - $3.07 $387,066 - $698,996	-227,686 Reduced 30.1%	528,667 $898,000
Q2 2023 Aug 09, 2023	SELL	$2.83 - $3.87 $30,363 - $41,521	-10,729 Reduced 1.4%	756,353 $2.27 Million
Q1 2023 May 10, 2023	BUY	$2.3 - $8.25 $254,839 - $914,100	110,800 Added 16.88%	767,082 $2.06 Million
Q4 2022 Feb 13, 2023	BUY	$6.29 - $11.01 $783,073 - $1.37 Million	124,495 Added 23.41%	656,282 $5.41 Million
Q3 2022 Nov 09, 2022	BUY	$2.94 - $11.87 $105,895 - $427,545	36,019 Added 7.27%	531,787 $4.1 Million
Q2 2022 Aug 09, 2022	SELL	$2.13 - $5.38 $7,929 - $20,029	-3,723 Reduced 0.75%	495,768 $1.41 Million
Q1 2022 May 11, 2022	BUY	$4.38 - $18.78 $60,448 - $259,182	13,801 Added 2.84%	499,491 $2.5 Million
Q4 2021 Feb 10, 2022	SELL	$19.0 - $30.95 $67,925 - $110,646	-3,575 Reduced 0.73%	485,690 $9.53 Million
Q3 2021 Nov 10, 2021	BUY	$29.44 - $43.74 $1.95 Million - $2.9 Million	66,242 Added 15.66%	489,265 $14.4 Million
Q2 2021 Aug 13, 2021	SELL	$38.07 - $56.17 $46,216 - $68,190	-1,214 Reduced 0.29%	423,023 $17.9 Million
Q1 2021 May 13, 2021	SELL	$32.41 - $70.91 $2.45 Million - $5.36 Million	-75,634 Reduced 15.13%	424,237 $21.6 Million
Q4 2020 Feb 12, 2021	BUY	$31.02 - $35.16 $15.5 Million - $17.6 Million	499,871 New	499,871 $17 Million

Others Institutions Holding BCAB

# of Institutions

Shares Held

17.4M

Call Options Held

500

Put Options Held

33.5K

View Full List

About BioAtla, Inc.

Ticker BCAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,304,100
Market Cap $58.4M
Description
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...

More about BCAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Account

Massachusetts Financial Services CO Bio Atla, Inc. Transaction History